Latest Industry News & Trends

Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.

Device News

11/14/2024
DeviceNewsletterRegulationRetina
US FDA Grants De Novo Classification to LumiThera’s System for Dry AMD
US FDA Grants De Novo Classification to LumiThera’s System for Dry AMD

LumiThera announced Nov. 4 that the US FDA had granted market authorization through the de novo pathway for the Valeda photobio-modulation system for treatment of patients with dry age-related macu...

11/14/2024
AAODeviceEyeceleratorGlaucomaMeetingNewsletterSurgical
AAO and Eyecelerator Sessions Showcase Latest in Glaucoma Lasers and Surgical Devices
AAO and Eyecelerator Sessions Showcase  Latest in Glaucoma Lasers and Surgical Devices

New glaucoma lasers and surgical devices were shown at various venues during the 2024 AAO meeting, including Glaucoma Subspecialty Day and the Eyecelerator meeting. There was also an important upda...

11/14/2024
DeviceNewsletterRegulation
Michelle Tarver, MD, PhD, an Ophthalmologist, Named Director of FDA’s CDRH
Michelle Tarver, MD, PhD, an Ophthalmologist, Named Director of FDA’s CDRH

Michelle E. Tarver, MD, PhD, has been named director of the FDA’s Center for Devices and Radiological Health (CDRH), after serving as acting director since July 2024. She is a board-certified ophth...

11/8/2024
BreakingDeviceRegulationRetina
US FDA Grants De Novo Classification to LumiThera’s Photobiomodulation System for Dry AMD
US FDA Grants De Novo Classification to LumiThera’s Photobiomodulation System for Dry AMD

LumiThera announced Nov. 4 that the US FDA had granted market authorization through the de novo pathway for the Valeda photobiomodulation system for treatment of patients with dry age-related macul...

11/1/2024
BreakingDeviceRegulation
Michelle Tarver, MD, PhD, an Ophthalmologist, Named Director of FDA’s CDRH
Michelle Tarver, MD, PhD, an Ophthalmologist, Named Director of FDA’s CDRH

Michelle E. Tarver, MD, PhD, has been named director of the FDA’s Center for Devices and Radiological Health (CDRH), after serving as acting director since July 2024. She is a board-certified ophth...

10/15/2024
CataractDeviceNewsletter
Zeiss Begins Broad US Rollout of Micor 700 for Phaco-less Cataract Surgery
Zeiss Begins Broad US Rollout of Micor 700 for Phaco-less Cataract Surgery

Zeiss Medical Technology reported Sept. 26 that it had begun broad US distribution of the Micor 700, the first hand-held device to extract a crystalline lens in cataract surgery without the need fo...

10/15/2024
DeviceNewsletterRegulation
FDA Names New Leaders at OPEQ and CDHR
FDA Names New Leaders at OPEQ and CDHR

Ross Segan, MD, MBA, FACS, has become director of the US FDA’s Office of Product Evaluation and Quality (OPEQ). The office, part of FDA’s Center for Devices and Radiological Health (CDRH), oversees...

10/4/2024
BreakingDeviceRegulation
Ross Segan, MD, MBA, FACS, Takes Helm of FDA’s OPEQ
Ross Segan, MD, MBA, FACS, Takes Helm of FDA’s OPEQ

Ross Segan, MD, MBA, FACS, has becomedirector of the US FDA’s Office of Product Evaluation and Quality (OPEQ). The office, part of FDA’s Center for Devices and Radiological Health (CDRH), oversees ...

9/19/2024
DeviceDiagnosticGlaucomaNewsletter
Injectsense Reports First Human Implantation of Ultraminiature IOP Sensor
Injectsense Reports First Human Implantation of Ultraminiature IOP Sensor

Injectsense, of Emeryville, California, announced Aug. 27 that it had implanted its first ultraminiature wireless sensor for measuring intraocular pressure (IOP). Glaucoma specialist Juan Mura, MD,...

8/16/2024
BreakingDeviceRegulationRetina
LumiThera Gains CPT Code to Report Retinal PBM Therapy, a Step Toward Reimbursement
LumiThera Gains CPT Code to Report Retinal PBM Therapy, a Step Toward Reimbursement

LumiThera announced Aug. 7 that a new Category III CPT code had been established, effective Jan. 1, 2025, to report “Photobiomodulation therapy of retina, single session.” The company said the code...

7/23/2024
DeviceGlaucomaNewsletterSurgical
Multitude of Novel Glaucoma Surgery Devices to Drive Procedure Growth
Multitude of Novel Glaucoma Surgery Devices to Drive Procedure Growth

The goal of a growing number of companies entering the already crowded glaucoma device market is to provide surgical treatment options with greater safety and effectiveness. Thirty-six products are...

7/23/2024
DeviceGlaucomaNewsletterRegulation
IOP-Lowering Goggles Developed by John Berdahl, MD, Gain De Novo Certification for Marketing
IOP-Lowering Goggles Developed by John Berdahl, MD, Gain  De Novo Certification for Marketing

Balance Ophthalmics has gained US FDA de novo classification for its FSYX Ocular Pressure Adjusting Pump (FSYX OPAP) system, a goggles and pump system designed to lower intraocular pressure (IOP) i...

7/23/2024
DeviceNewsletterRegulation
Ophthalmic Devices to be Included in FDA TAP Accelerator Program
Ophthalmic Devices to be Included in FDA TAP Accelerator Program

The US FDA announced July 1 that it was expanding its TAP pilot program in October to include ophthalmic devices, as well as radiological health devices. The voluntary program, officially named the...

7/11/2024
BreakingDeviceRegulation
Ophthalmic Devices to be Included in FDA TAP Program
Ophthalmic Devices to be Included in FDA TAP Program

The US FDA announced July 1 that it was expanding its TAP pilot program in October to include ophthalmic devices, as well as radiological health devices. The voluntary program, officially named the...

7/5/2024
BreakingDeviceGlaucomaRegulation
IOP-Lowering Goggles Developed by John Berdahl, MD, Gain De Novo Nod for Marketing
IOP-Lowering Goggles Developed by John Berdahl, MD, Gain De Novo Nod for Marketing

Balance Ophthalmics has gained US FDA de novo classification for its FSYX Ocular Pressure Adjusting Pump (FSYX OPAP) system, a goggles and pump system designed to lower intraocular pressure (IOP) i...

6/24/2024
DeviceNewsletterPharmaRevenue
Ophthalmic Company Revenue Totals $11 Billion, a Drop of 0.2 Percent, in Q1-2024
Ophthalmic Company Revenue Totals $11 Billion, a Drop of 0.2 Percent, in Q1-2024

Ophthalmic manufacturer revenue in Q1-2024 totaled $11.0 billion. Revenue decreased 0.2 percent from the same quarter in 2023 and dropped 1.7 percent from Q4-2023. The total includes Market Scope e...

6/24/2024
CataractDeviceNewsletter
Innovations on Horizon are Expected to Rejuvenate Cataract Equipment Market
Innovations on Horizon are Expected  to Rejuvenate Cataract Equipment Market

Signs of innovation and renewal can be found in all segments of the cataract equipment market, despite evidence that the market has become mature. Innovation looms in next-generation ultrasonic pha...

6/14/2024
BreakingDeviceFundingProsthesisRetina
LambdaVision Reports First Closing of Seed Round to Advance Artificial Retina
LambdaVision Reports First Closing of Seed Round to Advance Artificial Retina

LambdaVision, of Farmington, Connecticut, reported May 29 that it had secured the first closing of a seed round, let by Aurelia Foundry Fund, a fund spun out of Massachusetts Institute of Technolog...

3/21/2024
DeviceNewsletterPharmaRetinaRevenue
Ophthalmic Company Revenue in Q4-2023 Rises 0.4 Percent
Ophthalmic Company Revenue in Q4-2023 Rises 0.4 Percent

Ophthalmic manufacturer revenue in Q4-2023 totaled $11.2 billion. Revenue increased 0.4 percent from the same quarter in 2022 and increased 1.0 percent from Q3-2023. The total includes Market Scope...

2/22/2024
AcquisitionsDeviceNewsletterRetinaSurgical
Retinal Device Market Awaits Technological Impact of Zeiss’ DORC Acquisition
Retinal Device Market Awaits Technological Impact of Zeiss’ DORC Acquisition

Carl Zeiss Meditec’s acquisition of DORC (Dutch Ophthalmic Research Center) will change the players in the retinal surgical equipment market, but whether it will lead to any major changes in market...

12/14/2023
CataractDeviceEarningsGlaucomaNewsletterPharmaRetinaRevenue
Ophthalmic Company Revenue Increases 3.4 Percent in Third Quarter of 2023
Ophthalmic Company Revenue Increases 3.4 Percent in Third Quarter of 2023

Ophthalmic manufacturer revenue in Q3-2023 totaled $11.1 billion. Revenue increased 3.4 percent from the same quarter in 2022 and decreased 2.7 percent from Q2-2023. The total includes Market Scope...

12/14/2023
DeviceDiagnosticNewsletterRefractiveRegulation
Select US FDA Approvals and Clearances in November 2023
Select US FDA Approvals and Clearances in November 2023

The US FDA granted three clearances through the ophthalmic device division using the 510(k) pathway in November 2023, according to the agency’s database. Medimaging Integrated Solution (MiiS) recei...

Want to Read the Full Article?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more